SMS Lifesciences India Ltd receives EIR from USFDA for API manufacturing facility

SMS Lifesciences India Ltd's API manufacturing facility located at Sy. No. 180/2. Kazipally. Jinnaram Mandal, Sangareddy district. Telangana. has received Establishment Inspection Report (EIR) from U.S. Food and Drug Administration (US FDA) for the inspection conducted in the month of April, 2022.

The EIR from US FDA Indicates successful completion ot the Inspection without any observations.

Shares of SMS Lifesciences India Limited was last trading in BSE at Rs. 653.80 as compared to the previous close of Rs. 675.25. The total number of shares traded during the day was 161 in over 40 trades.

The stock hit an intraday high of Rs. 674.60 and intraday low of 652.80. The net turnover during the day was Rs. 106120.00.

Source : Equity Bulls

Keywords

SMSLifesciencesIndia INE320X01016 EIR USFDA APIManufacturingFacility Telangana